Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Emicizumab in Hemophilia A: NCT04431726 Clinical Landscape Report 2026
16 October 2026
NCT04431726 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HIX-763 in Acute Chest Syndrome: NCT04443907 Clinical Landscape Report 2026
16 October 2026
NCT04443907 clinical landscape for Acute Chest Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant human coagulation factor VIII-Fc fusion protein (Gensciences) in Hemophilia A: NCT04456387 Clinical Landscape Report 2026
16 October 2026
NCT04456387 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Morphine Hydrochloride Hydrate in Dyspnea: NCT04497831 Clinical Landscape Report 2026
16 October 2026
NCT04497831 clinical landscape for Dyspnea: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hydroxycarbamide in Anemia, Sickle Cell: CTRI/2020/08/027022 Clinical Landscape Report 2026
16 October 2026
CTRI/2020/08/027022 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Marzeptacog alfa in Hemorrhage: NCT04489537 Clinical Landscape Report 2026
16 October 2026
NCT04489537 clinical landscape for Hemorrhage: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Yinfenidone Hydrochloride in Idiopathic Pulmonary Fibrosis: NCT04512170 Clinical Landscape Report 2026
16 October 2026
NCT04512170 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Isoquercetin in Hemoglobin SC Disease: NCT04514510 Clinical Landscape Report 2026
16 October 2026
NCT04514510 clinical landscape for Hemoglobin SC Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Idiopathic Inflammatory Myopathies: NCT04561557 Clinical Landscape Report 2026
16 October 2026
NCT04561557 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Buloxibutid in Idiopathic Pulmonary Fibrosis: NCT04533022 Clinical Landscape Report 2026
16 October 2026
NCT04533022 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Inebilizumab-cdon in Myasthenia Gravis: NCT04524273 Clinical Landscape Report 2026
16 October 2026
NCT04524273 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tebapivat in Anemia, Sickle Cell: NCT04536792 Clinical Landscape Report 2026
16 October 2026
NCT04536792 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.